Filter Results:
(14,212)
Show Results For
- All HBS Web
(14,212)
- People (46)
- News (3,930)
- Research (7,771)
- Events (74)
- Multimedia (300)
- Faculty Publications (5,625)
Show Results For
- All HBS Web
(14,212)
- People (46)
- News (3,930)
- Research (7,771)
- Events (74)
- Multimedia (300)
- Faculty Publications (5,625)
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- Research Summary
Why Do Consumers Contribute to Connected Goods? A Dynamic Game of Competition and Cooperation in Social Networks
Social network platforms and media rely on the voluntary contributions of individual users to stay relevant. Consumers (users) contribute content such as photographs, videos, tweets etc.: these are available to any of their friends or peers, but not... View Details
- 1972
- Book
Managing the Multinational Enterprise: Organization of the Firm and Ownership of the Subsidiary
By: John M. Stopford and L. T. Wells Jr.
Stopford, John M., and L. T. Wells Jr. Managing the Multinational Enterprise: Organization of the Firm and Ownership of the Subsidiary. NY: Basic Books, 1972, French ed.
- May 2009
- Teaching Note
The World Food Programme during the Global Food Crisis (TN) (A) and (B)
By: Eric D. Werker
Teaching Note for [709024] and [709052]. View Details
- November 2015
- Article
Influence of Experience and the Surgical Learning Curve on Long-term Patient Outcomes in Cardiac Surgery
By: Bryan M. Burt, Andrew W. ElBardissi, Robert S. Huckman, Lawrence H. Cohn, Marisa W. Cevasco, James D. Rawn, Sary F. Aranki and John G. Byrne
OBJECTIVE: We hypothesized that increased post-graduate surgical experience correlates with improved operative efficiency and long-term survival in standard cardiac surgery procedures.
METHODS: Utilizing a prospectively collected retrospective database,... View Details
METHODS: Utilizing a prospectively collected retrospective database,... View Details
Keywords: Service Delivery; Value; Health Care and Treatment; Experience and Expertise; Health Industry
Burt, Bryan M., Andrew W. ElBardissi, Robert S. Huckman, Lawrence H. Cohn, Marisa W. Cevasco, James D. Rawn, Sary F. Aranki, and John G. Byrne. "Influence of Experience and the Surgical Learning Curve on Long-term Patient Outcomes in Cardiac Surgery." Journal of Thoracic and Cardiovascular Surgery 150, no. 5 (November 2015): 1061–1067.
- 01 Dec 2000
- News
Latin America's Decade
laws and shareholder rights — are not well established. There's much less competition, but if you are a sharp Harvard MBA who wants to launch a start-up, many of the details will be more difficult in Latin... View Details
Keywords: Garry Emmons and Julia Hanna; Latin America; research; infrastructure; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments
- May 2025 (Revised June 2025)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (D)
By: Linda A. Hill and Lydia Begag
This fourth installment in the Pfizer Global Clinical Supply (GCS) transformation case series highlights how over a decade of cultural and digital evolution positioned GCS to meet unprecedented global challenges. In 2011, Michael Ku became the Vice President of GCS and... View Details
Keywords: Innovation Leadership; Technological Innovation; Leadership Development; Leadership Style; Research and Development; Science-Based Business; Transformation; Health Industry; Health Industry; Health Industry; United States; Asia; Europe; Latin America
Hill, Linda A., and Lydia Begag. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (D)." Harvard Business School Supplement 425-079, May 2025. (Revised June 2025.)
- Web
The MOC Affiliate Network Impact - Institute For Strategy And Competitiveness
historical prospective of the growth and outreach of the MOC Affiliate Network as well as showcase the depth of the MOC content and its impact around the world. MOC IMPACT... View Details
- January 2020
- Teaching Note
GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A) and (B)
This teaching note is meant to accompany “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A),” HBS No. 820-041, and “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (B),” HBS No. 820-074. The cases follow Nitin Thakor, President... View Details
- Article
Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures.
By: Ariel Dora Stern
The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated—a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and... View Details
Stern, Ariel Dora. "Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures." Journal of Law, Medicine & Ethics 47, no. 3 (September 2019): 396–397.
- October 18, 2024
- Article
Why Workplace Well-Being Programs Don’t Achieve Better Outcomes
By: Jazz Croft, Acacia Parks and Ashley Whillans
By 2026, global corporate spending on wellness programs is set to top $94.6 billion, yet anticipated improvements in well-being are not being realized,
and, in fact, mental health needs are continuing to rise around the world. Drawing on a large body of recent... View Details
Croft, Jazz, Acacia Parks, and Ashley Whillans. "Why Workplace Well-Being Programs Don’t Achieve Better Outcomes." Harvard Business Review Digital Articles (October 18, 2024).
- 2015
- Working Paper
Do People Shape Cities, or Do Cities Shape People? The Co-evolution of Physical, Social, and Economic Change in Five Major U.S. Cities
By: Nikhil Naik, Scott Duke Kominers, Ramesh Raskar, Edward L. Glaeser and Cesar Hidalgo
Urban change involves transformations in the physical appearance and the social composition of neighborhoods. Yet, the relationship between the physical and social components of urban change is not well understood due to the lack of comprehensive measures of... View Details
Naik, Nikhil, Scott Duke Kominers, Ramesh Raskar, Edward L. Glaeser, and Cesar Hidalgo. "Do People Shape Cities, or Do Cities Shape People? The Co-evolution of Physical, Social, and Economic Change in Five Major U.S. Cities." Working Paper.
- 17 Sep 2015
- News
Seattle and Cleveland Alumni Connect Around a ‘Vision’ for the New HBS
classmates and meet other alumni in the region, as well as with HBS faculty members and administrators. The evening featured remarks by Dean Nitin Nohria, Professor Thomas R.... View Details
- fall 2002
- Article
Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
- spring 1996
- Article
Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery." RAND Journal of Economics 27, no. 1 (spring 1996): 32–59.